van Dam, Sipko
Folkertsma, Pytrik
Castela Forte, Jose
de Vries, Dylan H.
Herrera Cunillera, Camila
Gannamani, Rahul
Wolffenbuttel, Bruce H. R.
Funding for this research was provided by:
Universitair Medisch Centrum Groningen (PPP-2019_023)
Ancora Health
Article History
Received: 25 May 2022
Accepted: 5 January 2023
First Online: 20 February 2023
Competing interests
: I have read the journal's policy and the authors of this manuscript have the following competing interests: Sipko van Dam, Pytrik Folkertsma, Jose Castela Forte, Dylan H. de Vries and Rahul Gannamani are employed by and Camila Herrera Cunillera is associated with Ancora Health B.V., a for profit organisation. Bruce Wolffenbuttel sits on the medical advisory board of Ancora Health B.V. Additionally, Jose Castela Forte and Rahul Gannamani own shares of Ancora Health B.V. The funder provided support in the form of salaries for all employees but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.